Researcher.Life Logo

Clinical Pharmacology and Therapeutics : Impact Factor & More

eISSN: 1532-6535pISSN: 0009-9236

Key Metrics

CiteScore
10.7
Impact Factor
5 - 10
Scite Index
0.89 5-Year SI
SNIP
1.83
Recommended pre-submission checks
Powered by Paperpal by Editage

Clinical Pharmacology and Therapeutics Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
Overview
Publisher WILEY
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1960
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Clinical Pharmacology and Therapeutics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Clinical Pharmacology and Therapeutics

Serious Infection Risk With TNF Inhibitors vs. JAK Inhibitors in Rheumatoid Arthritis: A Nationwide Claims-Based Cohort Study.
  • 1 May 2026
  • Clinical pharmacology and therapeutics
Analysis of Real-World Data Utilization in the Orphan Drug Approval Process: Focusing on New Drug Marketing Applications Submitted to the FDA.
  • 1 May 2026
  • Clinical pharmacology and therapeutics
Population Time-to-Event Modeling of Pregnancy Loss Risk Following Frozen Embryo Transfer: A Real-World Study in Chinese Women.
  • 1 May 2026
  • Clinical pharmacology and therapeutics
Emulating Six Cardiovascular Outcome Trials of Antidiabetic Drugs in Individuals with Type 2 Diabetes: Analyses Based on Real-World Databases from Korea and Taiwan.
  • 1 May 2026
  • Clinical pharmacology and therapeutics
Off-the-Shelf Large Language Models for Guiding Pharmacoepidemiological Study Design.
  • 1 May 2026
  • Clinical pharmacology and therapeutics
Post hoc Population Standardization of Trial Emulation Studies in Claims Data: An RCT-DUPLICATE Analysis.
  • 1 May 2026
  • Clinical pharmacology and therapeutics
Serious Infection Risk With TNF Inhibitors vs. JAK Inhibitors in Rheumatoid Arthritis: A Nationwide Claims-Based Cohort Study.
  • 1 May 2026
  • Clinical pharmacology and therapeutics
Analysis of Real-World Data Utilization in the Orphan Drug Approval Process: Focusing on New Drug Marketing Applications Submitted to the FDA.
  • 1 May 2026
  • Clinical pharmacology and therapeutics
Population Time-to-Event Modeling of Pregnancy Loss Risk Following Frozen Embryo Transfer: A Real-World Study in Chinese Women.
  • 1 May 2026
  • Clinical pharmacology and therapeutics
Emulating Six Cardiovascular Outcome Trials of Antidiabetic Drugs in Individuals with Type 2 Diabetes: Analyses Based on Real-World Databases from Korea and Taiwan.
  • 1 May 2026
  • Clinical pharmacology and therapeutics
Off-the-Shelf Large Language Models for Guiding Pharmacoepidemiological Study Design.
  • 1 May 2026
  • Clinical pharmacology and therapeutics
Post hoc Population Standardization of Trial Emulation Studies in Claims Data: An RCT-DUPLICATE Analysis.
  • 1 May 2026
  • Clinical pharmacology and therapeutics

FAQs on Clinical Pharmacology and Therapeutics